PER 3.85% 13.5¢ percheron therapeutics limited

Ann: ANP to present at Several Upcoming Virtual Conferences, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 94 Posts.
    lightbulb Created with Sketch. 22
    I thought it was a pretty good presentation. Good to hear we will spend the funds to go through to Ph2b by ourselves but there was no mention of any partnership during the call - so does this mean we are going alone and partner after successful Ph2b trails ? A bit riskier to not have backing but if they are so positive with their findings it will ensure we create more leverage when we do negotiate with a potential partner for ALT1102

    As for ALT1103 it does look like we will partner and as per the below slide if these milestones are in chronological order it means the announcement is imminent as in the prior slides he has EU Phase 2b Trial Application being submitted early 2021

    https://hotcopper.com.au/data/attachments/2707/2707351-a6b15069826267689877fea1f52a6875.jpg

    Lets see where it takes us
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
13.5¢
Change
0.005(3.85%)
Mkt cap ! $117.2M
Open High Low Value Volume
13.5¢ 13.5¢ 13.5¢ $26.35K 195.2K

Buyers (Bids)

No. Vol. Price($)
11 567374 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 134996 2
View Market Depth
Last trade - 10.13am 14/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.